本次大会于29日特设急性冠脉综合征(ACS)患者心力衰竭诊治分论坛,《国际循环》邀请南京鼓楼医院的王涟教授对分论坛的内容进行精彩解读。 AHF、NSTEMI或其他原因导致的肌钙蛋白增高 ACS包括急性心肌梗死(AMI)和不稳定心绞痛(UA)。临床上因UA引发的急性心...
Heart failure (HF) is a complex clinical syndrome caused by structural or functional impairment of ventricular filling and/or ejection of blood. The three main underlying causes of HF are coronary ...
To recall the management of acute heart failure or exacerbation of HF, remember LMNOP: Lasix/Loop diuretic Morphine (for ACS) Nitroglycerin Oxygen Position or Prop up the patientLong-term management of HF Lifestyle modifications[2,6,8,9,17,20] Lifestyle modifications decrease morbidity and mortal...
Chronic heart failureA complex condition, long-term management of chronic heart failure demands an understanding of the underlying causes and symptoms as well as the skills and knowledge to provide an effective treatment that can offer quality of life for the patient. To do this, acquaintance with...
heart failure, and other cardiovascular diseases. In this article, its role as a ‘biosensor’ of vascular inflammation is highlighted with description of recent imaging technologies that visualize PVAT in clinical practice,...
Interventions for heart failure Acute heart failureDefining, managing and treating the rapid onset of acute heart failure requires skills and techniques in constant evolution. The various topics of specific interest for this condition, from the latest tools, assist devices and techniques to biosensors ...
Heart failure (HF) is a major health problem affecting millions of people worldwide. The report about heart disease and stroke statistics claimed that almost 6.0 million Americans ≥20 years of age had HF based on the results of 2015-2018 The National Health and Nutrition Examination Survey (NH...
Acute heart failure in the setting of acute coronary syndromes (ACS) is a life-threatening situation that requires early identification and treatment. It may occur as the first manifestation of heart failure or in patients with previous heart disease, left ventricular dysfunction, and chronic symptoms...
Practice guidelines for patients with ST-segment elevation and non-ST-segment elevation acute coronary syndrome (NSTE-ACS) have changed in response to evidence from randomized trials, which showed a clear positive outcome from pharmacologic and interventional treatments. An analysis of data from the ...
and established cut-off points (<1200 ng/L, 1200–1800 ng/L, and >1800 ng/L) were used to evaluate its prognostic performance for CV death/hospitalization for heart failure (HHF), major adverse cardiovascular events (...